Sinemet Information

DRUG USED FOR: The drug is used for the treatment of Parkinson's disease and syndrome.

2) Consumer Medicine Information (msd-australia.com.au)

DRUG INFORMATION: The FDA source was used, which turns out to parallel the information given by the drug manufacturer. It was considered a reliable source because the FDA approved the drug in 1973. The proprietary name of the drug is Sinemet, and it's is a compound of carbidopa-levodopa. Carbidopa, an inhibitor of aromatic amino acid decarboxylation, is a white, crystalline compound, slightly soluble in water, having a molecular weight of 244.3. Its chemical designation is (-)-L?-hydrazino-?-methyl-?-(3,4-dihydroxybenzene) propanoic acid monohydrate. Levodopa is an aromatic amino acid, and is also a white, crystalline compound, slightly soluble in water, with a molecular weight of 197.2. It's chemical designation is (-)-L?-amino-?-(3, 4,-dihydroxybenzene) propanoic acid.

RATIONALE FOR DRUG USE: Patients with Parkinson's disease, a progressive neurodegenerative disorder of the extrapyramidal nervous system, which affects the control and mobility of the skeletal muscular system, have characteristic tremors, rigidity, and bradykinetic movements which can be imp

. . .
Some common words found in the essay are:
SUPPLIED Sinemet, Sinemet Sinemet, Patients Parkinson's, INFORMATION FDA, Parkinson's Disease, , CONTRAINDICATIONS Nonelective, Medicine Information, Move Inc, Carbidopa-levodopa DRUG, sept 2005, 28 sept, 28 sept 2005, mg levodopa, nervous system, mg carbidopa, parkinson's disease, compound slightly soluble, white crystalline, crystalline compound, tablet times, compound slightly, slightly soluble water, white crystalline compound, aromatic amino acid,
Approximate Word count = 842
Approximate Pages = 3 (250 words per page)

More Essays on Sinemet Information